EUVIMEDEUVIMED entdecken
Open Access

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium

Edo Kon iD, Yinon Levy, Uri Elia iD, Hila Cohen, Inbal Hazan-Halevy iD, Moshe Aftalion, Assaf Ezra, Erez Bar-Haim iD, Gonna Somu Naidu iD, Yael Diesendruck, Shahar Rotem, Nitay Ad-El iD und 4 weitere

Science Advances · 10.03.2023 · 9 (10)

DOI: 10.1126/sciadv.adg1036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 10.03.2023. Verfasst von Edo Kon und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Precision NanoMedicine, Shmunis School for Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv Universit…. Hauptthemen laut MEDLINE: Plague, Plague Vaccine, Yersinia pestis. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) lipid nanoparticle (LNP) vaccines have emerged as an effective vaccination strategy. Although currently applied toward viral pathogens, data concerning the platform’s effectiveness against bacterial pathogens are limited. Here, we developed an effective mRNA-LNP vaccine against a lethal bacterial pathogen by optimizing mRNA payload guanine and cytosine content and antigen design. We designed a nucleoside-modified mRNA-LNP vaccine based on the bacterial F1 capsule antigen, a major protective component of Yersinia pestis , the etiological agent of plague. Plague is a rapidly deteriorating contagious disease that has killed millions of people during the history of humankind. Now, the disease is treated effectively with antibiotics; however, in the case of a multiple-antibiotic-resistant strain outbreak, alternative countermeasures are required. Our mRNA-LNP vaccine elicited humoral and cellular immunological responses in C57BL/6 mice and conferred rapid, full protection against lethal Y. pestis infection after a single dose. These data open avenues for urgently needed effective antibacterial vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlaguePlague VaccineYersinia pestisMiceAnimalsBacterial ProteinsMice, Inbred C57BLAntigens, Bacterial

Substanzen

Plague VaccineBacterial ProteinsAntigens, Bacterial

Autor:innen und Institutionen

  • Laboratory of Precision NanoMedicine, Shmunis School for Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
  • Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv 69978, Israel.
  • Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv 69978, Israel.
  • Cancer Biology Research Center, Tel Aviv University, Tel Aviv 69978, Israel.
  • Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 76100, Israel.

ORCID-Profile: Edo Kon, Uri Elia, Inbal Hazan-Halevy, Erez Bar-Haim, Gonna Somu Naidu, Nitay Ad-El, Meir Goldsmith, Emanuelle Mamroud, Dan Peer, Ofer Cohen

Zitieren

APA

Kon, E., Levy, Y., Elia, U., Cohen, H., Hazan-Halevy, I., Aftalion, M., Ezra, A., Bar-Haim, E., Naidu, G. S., Diesendruck, Y., Rotem, S., Ad-El, N., Goldsmith, M., Mamroud, E., Peer, D., & Cohen, O. (2023). A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science Advances, 9(10). https://doi.org/10.1126/sciadv.adg1036

Vancouver

Kon E, Levy Y, Elia U, Cohen H, Hazan-Halevy I, Aftalion M, et al. A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science Advances. 2023;9(10). doi:10.1126/sciadv.adg1036

BibTeX
@article{Kon2023,
  author = {Kon, Edo and Levy, Yinon and Elia, Uri and Cohen, Hila and Hazan-Halevy, Inbal and Aftalion, Moshe and Ezra, Assaf and Bar-Haim, Erez and Naidu, Gonna Somu and Diesendruck, Yael and Rotem, Shahar and Ad-El, Nitay and Goldsmith, Meir and Mamroud, Emanuelle and Peer, Dan and Cohen, Ofer},
  title = {A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {10},
  doi = {10.1126/sciadv.adg1036}
}
Kostenlos starten →